Elicera Therapeutics AB's total assets for Q4 2024 were kr27.56M, a decrease of -11.41% from the previous quarter. SE:ELIC total liabilities were kr6.79M for the fiscal quarter, a -12.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.